Subscriptions are live: We're on the subscription model now, early-access price $24.99/month, with day, week, and longer plans too. New accounts start with 5 free premium days. Prefer to donate? Donations grant premium time and are logged on your profile page.

$ACRS

Aclaris Therapeutics, Inc.

XNAS

$6.14-3.38%$0.2150Prev $6.36LIVE Full chart Live alerts
No recent price bars, the chart lights up when ACRS starts printing.

Why is ACRS down today? It is at $6.14 (-3.38%), and our scanner flagged it 36 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment ACRS spikes, and full due diligence on ACRS — key stats, earnings, dilution and insider activity. Free.

Free alerts

Get free $ACRS alerts the moment volume spikes

Our scanner flagged $ACRS 36 times in the last 30 days. Create a free account to track $ACRS, build a watchlist, and get instant unusual-volume alerts — plus 5 free premium days, no card needed.

Real-time RVOL & momentum alerts Personal watchlist & price alerts
Sign up free with email

No card · 5 premium days · join 800+ traders

Key Stats

Price & performance
Price
$6.14
Change today
-3.38%
Previous close
$6.36
52-week range
$1.52 – $6.51
Valuation & dividend
Market cap
$888M
Ownership & volume
Shares outstanding
139.7M
SEC · as of 2026-04-30 · 98d
Insider ownership
4.9%
DEF 14A · 2026-04-23
Institutional own.
85.29%
Total held
90.2%
Tradeable float
13.7M
10% of shares · after 5% insiders + 85% institutions
Short interest
13.4M
▲ +17% vs prior · as of 2026-07-15
Short % of float
97.4%
Days to cover
6.9d
Avg daily volume
1.6M
Classification
Exchange
XNAS
Relative volumevs this time of day
5m
0.3x
15m
0.8x
1h
0.9x
1D
0.1x

Get free ACRS + market alerts in your inbox

The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.

No spam. Unsubscribe anytime. Not investment advice.

Why is $ACRS down today?

1 alert todaySEC filing

ACRS is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 1 unusual-volume and momentum alert on ACRS today. Fresh from the SEC: Aclaris Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate and Clinical Update. A material company disclosure like this is often the real catalyst behind a move of this size.

Likely catalystAclaris Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate and Clinical Update, from the latest SEC filing. Read it →
Why is $ACRS moving? →▶ Replay the moveAuto-generated from live scanner data. Not investment advice.
Trading profileLow float · 13.7M sh🔥 Heavily shorted · 97% of floatShortableEasy to borrowNo SSRBorrow via Alpaca · SSR from Reg SHO 201
Wall Street consensusStrong Buy8 analysts
Avg target $10.75(+75% upside)
Range $4 – $16
7 buy1 hold0 sell

Analyst data via Nasdaq. Not investment advice.

Insiders

0 buys, 1 sells last 3 months (0/14 over 12 months)
Show 12 recent transactions
InsiderActionShares% of positionOwns afterValueDate
Kolbeck Roland Wilhelm
Officer
Sold (automatic/other)-12Ksold 34%24K$64K
at $5.20
Aug 1, 26
Kolbeck Roland Wilhelm
Officer
Other36K
0.03% of company
n/a36Kn/aAug 1, 26
Gowen Maxine
Director
Other12Kadded 53%33Kn/aJun 5, 26
Mehra Anand
Director
Other12Kadded 1.6%726Kn/aJun 5, 26
Humphries William D.
Director
Other12Kadded 35%45Kn/aJun 5, 26
Schiff Andrew N
Director
Other12Kadded 83%26Kn/aJun 5, 26
Milano Vincent
Director
Other12Kadded 67%29Kn/aJun 5, 26
Molineaux Christopher P.
Director
Other12Kadded 20%70Kn/aJun 5, 26
Hall Jesse Wayne
Officer
Sold (automatic/other)-9Ksold 26%27K$41K
at $4.41
May 1, 26
Hall Jesse Wayne
Officer
Other36K
0.03% of company
n/a36Kn/aMay 1, 26
Leonard Braden Michael
Beneficial Owner (10%)
Sold (automatic/other)-300K
0.2% of company
sold 2.1%13.95M$1.4M
at $4.53
Apr 23, 26
Balthaser Kevin
Officer
Sold (automatic/other)-677sold 0.4%187K$2K
at $2.87
Mar 1, 26

Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.

$ACRS Sentiment

Bullish
Bearish69Bullish
📰 News: 3 bull · 0 bearToday: -3.4%👥 Community: 0 bull · 0 bear

Blend of news sentiment, today’s move, and community votes. Not investment advice.

$ACRS Activity

News, unusual-volume alerts, AI-trader trades and community chatter — the whole story, newest first.

Alert· 55m ago
The Watcher BOUGHT $ACRS at $6.4000 __THOTH_JSON__{"side":"buy","strategyLabel":"The Watcher · swing","reason":"swing entry · breakout-daily","shares":17,"instance":"Rider","setup":"breakout-daily"}
at $6.40
News· SEC EDGAR· 7h ago
Aclaris Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate and Clinical Update
Alert· 18h ago +1.20%
$ACRS moved +1.20% in 1 min (Level 1) at 3:47 PM ET
at $6.33
Alert· 18h ago 4.0× RVOL
ACRS hit 4.003x RVOL at 3:47 PM ET
at $6.32
Alert· 20h ago +1.0% vs EMA
$ACRS near 200 EMA: +1.05% from 200 EMA at 2:35 PM ET
at $6.33
Alert· 20h ago 2.7× RVOL
ACRS hit 2.672x RVOL at 2:35 PM ET
at $6.33
Alert· 20h ago +1.77%
$ACRS moved +1.77% in 1 min (Level 1) at 2:09 PM ET
at $6.39
Alert· 20h ago
The Watcher SOLD $ACRS at $6.3400 __THOTH_JSON__{"side":"sell","strategyLabel":"The Watcher · day","reason":"level_fail","shares":10,"instance":"Rider"}
at $6.34
Alert· 20h ago
The Watcher BOUGHT $ACRS at $6.4200 __THOTH_JSON__{"side":"buy","strategyLabel":"The Watcher · day","reason":"day entry · topplay-first(5m)","shares":10,"instance":"Rider","setup":"topplay-first(5m)"}
at $6.42
Alert· 20h ago
The Watcher SOLD $ACRS at $6.4100 __THOTH_JSON__{"side":"sell","strategyLabel":"The Watcher · scalp","reason":"level_fail","shares":10,"instance":"Rider","setup":"topplay-first(1m)"}
at $6.41
Alert· 20h ago
The Watcher BOUGHT $ACRS at $6.4700 __THOTH_JSON__{"side":"buy","strategyLabel":"The Watcher · scalp","reason":"scalp entry · topplay-first(1m)","shares":10,"instance":"Rider","setup":"topplay-first(1m)"}
at $6.47
Alert· 20h ago 28.9× RVOL
ACRS hit 28.845x RVOL at 1:48 PM ET
at $6.50
Alert· 21h ago +1.43%
$ACRS moved +1.43% in 1 min (Level 1) at 1:23 PM ET
at $6.41
Alert· 21h ago +2.9% vs EMA
$ACRS near 200 EMA: +2.94% from 200 EMA at 1:05 PM ET
at $6.30
Alert· 21h ago 29.0× RVOL
ACRS hit 29.019x RVOL at 1:05 PM ET
at $6.30
Alert· 21h ago +2.9% vs EMA
$ACRS near 200 EMA: +2.89% from 200 EMA at 12:57 PM ET
at $6.29
Alert· 21h ago +1.45%
$ACRS moved +1.45% in 1 min (Level 1) at 12:57 PM ET
at $6.29
Alert· 22h ago 47.1× RVOL
ACRS hit 47.096x RVOL at 12:17 PM ET
at $6.20
Alert· 1d ago +2.0% vs EMA
$ACRS near 200 EMA: +2.01% from 200 EMA at 2:27 PM ET
at $5.92
Alert· 1d ago 12.8× RVOL
ACRS hit 12.767x RVOL at 2:27 PM ET
at $5.92
Alert· 1d ago 2.0× RVOL
ACRS hit 2.000x RVOL at 2:07 PM ET
at $5.89
Alert· 1d ago 10.4× RVOL
ACRS hit 10.397x RVOL at 1:11 PM ET
at $5.92
Alert· 1d ago +1.54%
$ACRS moved +1.54% in 1 min (Level 1) at 12:41 PM ET
at $5.95
Alert· 1d ago -1.03%
$ACRS moved -1.03% in 1 min (Level 1) at 12:16 PM ET
at $5.84
Alert· 1d ago 52.7× RVOL
ACRS hit 52.675x RVOL at 12:16 PM ET
at $5.89
Alert· 1d ago 16.7× RVOL
ACRS hit 16.671x RVOL at 12:14 PM ET
at $5.86
News· SEC EDGAR· 62d ago
Aclaris Therapeutics, Inc. filed an 8-K: Shareholder Vote
News· SEC EDGAR· 90d ago
Aclaris Therapeutics, Inc. filed a Quarterly report (10-Q)
News· SEC EDGAR· 91d ago
Aclaris Therapeutics, Inc. filed an 8-K: Results of Operations
News· GlobeNewswire Inc.· 138d ago Bullish
Aclaris Therapeutics Announces Poster on Results from Phase 2a Trial of ATI-2138 at the 2026 American Academy of Dermatology (AAD) Annual Meeting
News· GlobeNewswire Inc.· 163d ago Bullish
Aclaris Therapeutics Initiates Phase 1b Proof-of-Concept Trial in Patients with Asthma with its Novel Bispecific Anti-TSLP/IL-4Rα Antibody ATI-052
News· GlobeNewswire Inc.· 254d ago Neutral
Aclaris Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference
News· GlobeNewswire Inc.· 331d ago Bullish
Aclaris Therapeutics Announces Late-Breaking Abstract and Oral Presentation On ATI-2138 Phase 2a Results at the 2025 European Academy of Dermatology and Venereology (EADV) Congress

Also moving today

The tickers our scanner is lighting up most over the last 48 hours.

ACRS stock FAQ

Why is $ACRS down today?

ACRS is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 1 unusual-volume and momentum alert on ACRS today. Fresh from the SEC: Aclaris Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate and Clinical Update. A material company disclosure like this is often the real catalyst behind a move of this size.

What is the ACRS stock price today?

ACRS last traded at $6.14, down 3.38% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).

Where can I see live ACRS alerts?

The ACRS Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged ACRS 36 times in the last 30 days.

What exchange is ACRS on?

ACRS (Aclaris Therapeutics, Inc.) trades on XNAS, with a market cap of about $888M.

Is ACRS good for day trading?

That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge ACRS for yourself. This is not investment advice.

Live data from TheDesperateTrader scanner. Not investment advice.